Goldman Sachs’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.43M Buy
376,284
+194,209
+107% +$3.32M ﹤0.01% 2606
2025
Q1
$11.6M Sell
182,075
-294,991
-62% -$18.8M ﹤0.01% 2119
2024
Q4
$58M Buy
477,066
+176,045
+58% +$21.4M 0.01% 983
2024
Q3
$37.6M Sell
301,021
-138,556
-32% -$17.3M 0.01% 1262
2024
Q2
$69.5M Buy
439,577
+189,530
+76% +$29.9M 0.01% 837
2024
Q1
$32.4M Buy
250,047
+65,177
+35% +$8.44M 0.01% 1238
2023
Q4
$17.8M Sell
184,870
-558,022
-75% -$53.8M ﹤0.01% 1655
2023
Q3
$90.1M Sell
742,892
-226,396
-23% -$27.4M 0.02% 660
2023
Q2
$111M Buy
969,288
+211,216
+28% +$24.2M 0.02% 577
2023
Q1
$104M Sell
758,072
-480,755
-39% -$66.3M 0.02% 593
2022
Q4
$161M Buy
1,238,827
+102,134
+9% +$13.2M 0.04% 428
2022
Q3
$126M Sell
1,136,693
-274,230
-19% -$30.3M 0.03% 505
2022
Q2
$106M Buy
1,410,923
+486,867
+53% +$36.5M 0.03% 569
2022
Q1
$72.2M Sell
924,056
-82,149
-8% -$6.42M 0.02% 845
2021
Q4
$90.6M Buy
1,006,205
+133,210
+15% +$12M 0.02% 741
2021
Q3
$80.7M Sell
872,995
-17,004
-2% -$1.57M 0.02% 765
2021
Q2
$69.2M Buy
889,999
+175,587
+25% +$13.7M 0.02% 860
2021
Q1
$53.2M Sell
714,412
-335,605
-32% -$25M 0.01% 1000
2020
Q4
$179M Sell
1,050,017
-204,564
-16% -$34.9M 0.05% 323
2020
Q3
$176M Buy
1,254,581
+1,393
+0.1% +$196K 0.05% 328
2020
Q2
$201M Sell
1,253,188
-72,684
-5% -$11.7M 0.06% 279
2020
Q1
$130M Buy
1,325,872
+217,352
+20% +$21.3M 0.05% 379
2019
Q4
$143M Buy
1,108,520
+81,222
+8% +$10.5M 0.04% 474
2019
Q3
$77.4M Buy
1,027,298
+464,818
+83% +$35M 0.02% 743
2019
Q2
$85.5M Sell
562,480
-110,793
-16% -$16.8M 0.02% 716
2019
Q1
$80.2M Buy
673,273
+41,069
+6% +$4.89M 0.02% 731
2018
Q4
$69M Buy
632,204
+94,960
+18% +$10.4M 0.02% 754
2018
Q3
$86.8M Sell
537,244
-298,470
-36% -$48.2M 0.02% 770
2018
Q2
$110M Buy
835,714
+152,785
+22% +$20.2M 0.03% 612
2018
Q1
$50.6M Sell
682,929
-56,886
-8% -$4.21M 0.01% 1056
2017
Q4
$41.2M Buy
739,815
+74,852
+11% +$4.16M 0.01% 1183
2017
Q3
$30.2M Sell
664,963
-149,005
-18% -$6.76M 0.01% 1347
2017
Q2
$27.4M Buy
813,968
+281,076
+53% +$9.48M 0.01% 1379
2017
Q1
$15.8M Buy
532,892
+294,529
+124% +$8.72M ﹤0.01% 1632
2016
Q4
$6.54M Sell
238,363
-44,620
-16% -$1.22M ﹤0.01% 2034
2016
Q3
$17.4M Sell
282,983
-158,793
-36% -$9.75M 0.01% 1548
2016
Q2
$8.42M Buy
441,776
+326,849
+284% +$6.23M ﹤0.01% 1854
2016
Q1
$2.24M Buy
114,927
+100,042
+672% +$1.95M ﹤0.01% 2455
2015
Q4
$575K Sell
14,885
-11,314
-43% -$437K ﹤0.01% 3177
2015
Q3
$841K Sell
26,199
-80,609
-75% -$2.59M ﹤0.01% 3011
2015
Q2
$3.25M Buy
106,808
+47,547
+80% +$1.45M ﹤0.01% 2313
2015
Q1
$787K Sell
59,261
-27,720
-32% -$368K ﹤0.01% 3048
2014
Q4
$1.26M Buy
86,981
+63,757
+275% +$923K ﹤0.01% 2785
2014
Q3
$490K Sell
23,224
-15,652
-40% -$330K ﹤0.01% 3346
2014
Q2
$1.16M Buy
38,876
+16,708
+75% +$498K ﹤0.01% 2885
2014
Q1
$533K Buy
22,168
+15,320
+224% +$368K ﹤0.01% 3339
2013
Q4
$139K Sell
6,848
-2,087
-23% -$42.4K ﹤0.01% 4012
2013
Q3
$422K Sell
8,935
-136,630
-94% -$6.45M ﹤0.01% 3412
2013
Q2
$5.54M Buy
+145,565
New +$5.54M ﹤0.01% 1701